CATALANO, ROSA
 Distribuzione geografica
Continente #
NA - Nord America 2.975
EU - Europa 2.282
AS - Asia 2.068
SA - Sud America 193
AF - Africa 79
OC - Oceania 9
Totale 7.606
Nazione #
US - Stati Uniti d'America 2.889
DE - Germania 898
CN - Cina 669
SG - Singapore 561
IT - Italia 536
BD - Bangladesh 210
GB - Regno Unito 189
VN - Vietnam 181
HK - Hong Kong 177
SE - Svezia 155
BR - Brasile 150
RU - Federazione Russa 102
FR - Francia 96
IN - India 87
NL - Olanda 72
CA - Canada 64
CI - Costa d'Avorio 40
FI - Finlandia 39
ID - Indonesia 34
ES - Italia 32
JP - Giappone 32
TR - Turchia 28
DK - Danimarca 26
IE - Irlanda 26
KR - Corea 24
AR - Argentina 21
UA - Ucraina 15
MX - Messico 14
RO - Romania 14
PL - Polonia 13
AT - Austria 12
ZA - Sudafrica 12
BE - Belgio 11
CH - Svizzera 11
AU - Australia 7
CO - Colombia 6
EG - Egitto 6
IQ - Iraq 6
PH - Filippine 6
SK - Slovacchia (Repubblica Slovacca) 6
TW - Taiwan 6
EC - Ecuador 5
MY - Malesia 5
NE - Niger 5
PK - Pakistan 5
SC - Seychelles 5
BY - Bielorussia 4
IL - Israele 4
KG - Kirghizistan 4
VE - Venezuela 4
CR - Costa Rica 3
HR - Croazia 3
IR - Iran 3
LB - Libano 3
LT - Lituania 3
MA - Marocco 3
NP - Nepal 3
PE - Perù 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
JO - Giordania 2
LV - Lettonia 2
MD - Moldavia 2
MM - Myanmar 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
SI - Slovenia 2
TN - Tunisia 2
UZ - Uzbekistan 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CL - Cile 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KE - Kenya 1
LU - Lussemburgo 1
MK - Macedonia 1
MU - Mauritius 1
NA - Namibia 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
YE - Yemen 1
Totale 7.606
Città #
Dallas 1.170
Hanover 657
Ashburn 306
Singapore 287
Milan 174
San Jose 161
Southend 150
Hong Kong 144
Chandler 136
Frankfurt am Main 102
Santa Clara 98
Beijing 91
Hefei 82
Los Angeles 80
New York 77
Council Bluffs 61
Ho Chi Minh City 53
Munich 45
Ann Arbor 43
Abidjan 40
Houston 37
Fairfield 36
Lauterbourg 36
Hanoi 35
Bengaluru 34
Buffalo 32
Rome 27
Princeton 26
Toronto 26
Dublin 25
Moscow 24
Redwood City 24
Shanghai 23
Woodbridge 22
Guangzhou 21
Jakarta 21
Dearborn 20
Columbus 19
Helsinki 19
Seoul 19
Berlin 18
Seattle 18
São Paulo 18
Tokyo 18
Wilmington 18
Istanbul 17
Chicago 16
Padova 15
Cambridge 13
Cangzhou 13
Fremont 13
Jinan 13
Montreal 13
Zhengzhou 13
Nanjing 12
Tianjin 12
Turin 12
Johannesburg 11
Nuremberg 11
Da Nang 10
Des Moines 10
Haiphong 10
Córdoba 9
London 9
Orem 9
The Dalles 9
Turku 9
Hangzhou 8
Hải Dương 8
Mumbai 8
Naples 8
Boardman 7
Cinisello Balsamo 7
Grafing 7
Lappeenranta 7
Phoenix 7
Pittsburgh 7
San Diego 7
Shenzhen 7
Washington 7
Bologna 6
Brussels 6
Hebei 6
Madrid 6
Nantong 6
Ottawa 6
Plano 6
Rio de Janeiro 6
Sevilla 6
Amsterdam 5
Brooklyn 5
Farmington 5
Nanchang 5
Niamey 5
Palermo 5
Quanzhou 5
San Francisco 5
Shenyang 5
Trento 5
Valencia 5
Totale 5.036
Nome #
AZD1775: effect of monotherapy or EDP-M combination in the treatment of ACC preclinical models 457
Cofilin is a cAMP effector in mediating actin cytoskeleton reorganization and steroidogenesis in mouse and human adrenocortical tumor cells 448
Sphingosine kinase 1 inhibitor safingol as a new possible therapeutic strategy for adrenocortical carcinoma 433
Genetic profiling of a cohort of Italian patients with ACTH-secreting pituitary tumors and characterization of a novel USP8 gene variant 432
β-arrestin 2 is required for dopamine receptor type 2 inhibitory effects on AKT phosphorylation and cell proliferation in pituitary tumors 428
Cytoskeleton actin-binding proteins in clinical behavior of pituitary tumors 418
The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells 384
A novel mechanism regulating dopamine receptor type 2 (DRD2) signal transduction in pituitary tumoral cells: the role of cAMP/PKA-induced filamin A (FLNA) phosphorylation 384
Octreotide and pasireotide effects on medullary thyroid carcinoma (MTC) cells growth, migration and invasion 379
IGF2R: a new player in the insulin-like growth factor 2 (IGF2) pathway sustaining adrenocortical carcinoma cells growth 328
cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells 250
DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells 249
A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment 241
Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation. 222
Cytoskeleton protein Filamin A is required for efficient Somatostatin receptor type 2 internalization and recycling through Rab5 and Rab4 sorting endosomes in tumor somatotroph cells 207
Drug resistance in pituitary tumours: from cell membrane to intracellular signalling 187
Stem Cells in Pituitary Tumors: Experimental Evidence Supporting Their Existence and Their Role in Tumor Clinical Behavior 185
The Novel SSTR3 Agonist ITF2984 Exerts Antimitotic and Proapoptotic Effects in Human Non-Functioning Pituitary Neuroendocrine Tumor (NF-PitNET) Cells 183
Therapeutic potential of targeting the FLNA‐regulated Wee1 kinase in adrenocortical carcinomas 182
P720R USP8 Mutation Is Associated with a Better Responsiveness to Pasireotide in ACTH-Secreting PitNETs 177
TMPRSS2 Expression and Activity Modulation by Sex-Related Hormones in Lung Calu-3 Cells: Impact on Gender-Specific SARS-CoV-2 Infection 169
Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas 164
High Filamin a Expression in Adrenocortical Carcinomas Is Associated with a Favourable Tumour Behaviour: A European Multicentric Study 163
Dimerization of GPCRs: Novel insight into the role of FLNA and SSAs regulating SST2 and SST5 homo- and hetero-dimer formation 142
A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells 141
Preclinical evaluation of the antitumoral efficacy of Wee1 inhibitor AZD1775 in adrenocortical carcinoma 130
Therapeutic potential of targeting the FLNA-regulated Wee1 kinase in adrenocortical carcinomas 129
The novel SST3 agonist ITF2984 exerts antimitotic and proapoptotic effects in human non-functioning pituitary neuroendocrine tumor (NF-PitNET) cells 109
Pituitary tumors: genetic and molecular factors underlying pathogenesis and clinical behavior 109
Filamin A is required for somatostatin receptor type 5 expression and pasireotide-mediated signaling in pituitary corticotroph tumor cells 101
Role of filamin A in the pathogenesis of neuroendocrine tumors and adrenal cancer 96
USP8 inhibitor RA-9 reduces ACTH release and cell growth in tumor corticotrophs 89
The Cytoskeleton in Adrenal Physiology and Tumours: Functional Roles and Emerging Molecular Targets 71
Totale 7.787
Categoria #
all - tutte 19.017
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.017


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 0 0 0 0 0 23
2021/20221.070 19 35 53 124 151 139 135 104 132 62 25 91
2022/2023438 57 45 31 48 28 78 16 31 38 10 27 29
2023/2024451 22 23 15 33 131 13 51 39 16 29 32 47
2024/20251.084 31 61 25 97 99 53 34 103 59 150 138 234
2025/20264.055 305 1.281 336 266 222 134 327 114 279 191 351 249
Totale 7.787